Advertisement Mylan Pharma rolls out generic benign prostatic hyperplasia drug - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Mylan Pharma rolls out generic benign prostatic hyperplasia drug

Mylan Pharmaceuticals has introduced Alfuzosin Hydrochloride Extended-release Tablets, 10mg.

Mylan‘s Alfuzosin Hydrochloride Extended-release Tablets, 10mg are generic equivalent to Uroxatral, indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.

Uroxatral belongs to a group of drugs called alpha-adrenergic blockers.

Uroxatral relaxes the muscles in the prostate and bladder neck, making it easier to urinate.